443 related articles for article (PubMed ID: 24284085)
21. [Photodynamic diagnosis and fluorescence-guided resection of malignant gliomas: a report of 15 cases].
Cao Y; Zhang MZ; Zhao JZ; Zhang W; Wang L
Zhonghua Wai Ke Za Zhi; 2005 Mar; 43(5):334-8. PubMed ID: 15842947
[TBL] [Abstract][Full Text] [Related]
22. Malignancy assessment of brain tumours with magnetic resonance spectroscopy and dynamic susceptibility contrast MRI.
Fayed N; Dávila J; Medrano J; Olmos S
Eur J Radiol; 2008 Sep; 67(3):427-33. PubMed ID: 18442889
[TBL] [Abstract][Full Text] [Related]
23. An integrated diagnosis and therapeutic system using intra-operative 5-aminolevulinic-acid-induced fluorescence guided robotic laser ablation for precision neurosurgery.
Liao H; Noguchi M; Maruyama T; Muragaki Y; Kobayashi E; Iseki H; Sakuma I
Med Image Anal; 2012 Apr; 16(3):754-66. PubMed ID: 21183395
[TBL] [Abstract][Full Text] [Related]
24. Association of 5-aminolevulinic acid fluorescence guided resection with photodynamic therapy in recurrent glioblastoma: a matched cohort study.
da Silva EB; Vasquez MWM; de Almeida Teixeira BC; Neto MC; Sprenger F; Filho JLN; Almeida-Lopes L; Ramina R
Acta Neurochir (Wien); 2024 May; 166(1):212. PubMed ID: 38739282
[TBL] [Abstract][Full Text] [Related]
25. 5-ALA complete resections go beyond MR contrast enhancement: shift corrected volumetric analysis of the extent of resection in surgery for glioblastoma.
Schucht P; Knittel S; Slotboom J; Seidel K; Murek M; Jilch A; Raabe A; Beck J
Acta Neurochir (Wien); 2014 Feb; 156(2):305-12; discussion 312. PubMed ID: 24449075
[TBL] [Abstract][Full Text] [Related]
26. Aggressive resection at the infiltrative margins of glioblastoma facilitated by intraoperative fluorescein guidance.
Neira JA; Ung TH; Sims JS; Malone HR; Chow DS; Samanamud JL; Zanazzi GJ; Guo X; Bowden SG; Zhao B; Sheth SA; McKhann GM; Sisti MB; Canoll P; D'Amico RS; Bruce JN
J Neurosurg; 2017 Jul; 127(1):111-122. PubMed ID: 27715437
[TBL] [Abstract][Full Text] [Related]
27. Fluorescence-guided surgery in high grade gliomas using an exoscope system.
Belloch JP; Rovira V; Llácer JL; Riesgo PA; Cremades A
Acta Neurochir (Wien); 2014 Apr; 156(4):653-60. PubMed ID: 24468884
[TBL] [Abstract][Full Text] [Related]
28. Fluorescein Sodium in the Surgical Treatment of Recurrent Glioblastoma Multiforme.
Höhne J; Schebesch KM; de Laurentis C; Akçakaya MO; Pedersen CB; Brawanski A; Poulsen FR; Kiris T; Cavallo C; Broggi M; Ferroli P; Acerbi F
World Neurosurg; 2019 May; 125():e158-e164. PubMed ID: 30682505
[TBL] [Abstract][Full Text] [Related]
29. The Value of Intraoperative and Early Postoperative Magnetic Resonance Imaging in Low-Grade Glioma Surgery: A Retrospective Study.
Pala A; Brand C; Kapapa T; Hlavac M; König R; Schmitz B; Wirtz CR; Coburger J
World Neurosurg; 2016 Sep; 93():191-7. PubMed ID: 27288582
[TBL] [Abstract][Full Text] [Related]
30. Intraoperative MRI guidance and extent of resection in glioma surgery: a randomised, controlled trial.
Senft C; Bink A; Franz K; Vatter H; Gasser T; Seifert V
Lancet Oncol; 2011 Oct; 12(11):997-1003. PubMed ID: 21868284
[TBL] [Abstract][Full Text] [Related]
31. Endoscopic-assisted visualization of 5-aminolevulinic acid-induced fluorescence in malignant glioma surgery: a technical note.
Rapp M; Kamp M; Steiger HJ; Sabel M
World Neurosurg; 2014; 82(1-2):e277-9. PubMed ID: 23871813
[TBL] [Abstract][Full Text] [Related]
32. Intraoperative dynamic susceptibility contrast weighted magnetic resonance imaging (iDSC-MRI) - Technical considerations and feasibility.
Ulmer S; Helle M; Jansen O; Mehdorn HM; Nabavi A
Neuroimage; 2009 Mar; 45(1):38-43. PubMed ID: 19100843
[TBL] [Abstract][Full Text] [Related]
33. Fluorescence image-guided surgery of brain tumors: explained step-by-step.
Eljamel MS
Photodiagnosis Photodyn Ther; 2008 Dec; 5(4):260-3. PubMed ID: 19356667
[TBL] [Abstract][Full Text] [Related]
34. Impact of 5-aminolevulinic acid fluorescence-guided surgery on the extent of resection of meningiomas--with special regard to high-grade tumors.
Cornelius JF; Slotty PJ; Kamp MA; Schneiderhan TM; Steiger HJ; El-Khatib M
Photodiagnosis Photodyn Ther; 2014 Dec; 11(4):481-90. PubMed ID: 25117928
[TBL] [Abstract][Full Text] [Related]
35. Identification of MRI and 1H MRSI parameters that may predict survival for patients with malignant gliomas.
Li X; Jin H; Lu Y; Oh J; Chang S; Nelson SJ
NMR Biomed; 2004 Feb; 17(1):10-20. PubMed ID: 15011246
[TBL] [Abstract][Full Text] [Related]
36. Is it a glioblastoma? In dubio pro 5-ALA!
Kamp MA; Santacroce A; Zella S; Reichelt DC; Felsberg J; Steiger HJ; Cornelius JF; Sabel M
Acta Neurochir (Wien); 2012 Jul; 154(7):1269-73. PubMed ID: 22576268
[TBL] [Abstract][Full Text] [Related]
37. Correlation of factors predicting intraoperative brain shift with successful resection of malignant brain tumors using image-guided techniques.
Benveniste RJ; Germano IM
Surg Neurol; 2005 Jun; 63(6):542-8; discussion 548-9. PubMed ID: 15936381
[TBL] [Abstract][Full Text] [Related]
38. Awake surgery for WHO Grade II gliomas within "noneloquent" areas in the left dominant hemisphere: toward a "supratotal" resection. Clinical article.
Yordanova YN; Moritz-Gasser S; Duffau H
J Neurosurg; 2011 Aug; 115(2):232-9. PubMed ID: 21548750
[TBL] [Abstract][Full Text] [Related]
39. Intraoperative tumor segmentation and volume measurement in MRI-guided glioma surgery for tumor resection rate control.
Hata N; Muragaki Y; Inomata T; Maruyama T; Iseki H; Hori T; Dohi T
Acad Radiol; 2005 Jan; 12(1):116-22. PubMed ID: 15691732
[TBL] [Abstract][Full Text] [Related]
40. Coregistered fluorescence-enhanced tumor resection of malignant glioma: relationships between δ-aminolevulinic acid-induced protoporphyrin IX fluorescence, magnetic resonance imaging enhancement, and neuropathological parameters. Clinical article.
Roberts DW; Valdés PA; Harris BT; Fontaine KM; Hartov A; Fan X; Ji S; Lollis SS; Pogue BW; Leblond F; Tosteson TD; Wilson BC; Paulsen KD
J Neurosurg; 2011 Mar; 114(3):595-603. PubMed ID: 20380535
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
